{"id":"d013-placebo-of-d326-placebo-of-d337","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo of D326 and D337, D013 contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials. It is designed to match the appearance and administration route of the active investigational drugs while providing no therapeutic effect, allowing for blinded assessment of efficacy and safety.","oneSentence":"D013 is a placebo control formulation with no active pharmacological mechanism.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:26.136Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04312698","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of CKD-386","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2019-08-29","conditions":"Dyslipidemia Patients With Hypertension","enrollment":100},{"nctId":"NCT04388215","phase":"PHASE3","title":"Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2019-10-23","conditions":"Hypertension, Dyslipidemias","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Drugs are consist of antihypertensive agent and antihyperlipidemic agent"],"phase":"phase_3","status":"active","brandName":"D013, placebo of D326, placebo of D337","genericName":"D013, placebo of D326, placebo of D337","companyName":"Chong Kun Dang Pharmaceutical","companyId":"chong-kun-dang-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}